Seeing Is Believing
Currently out of the existing stock ratings of James Mainwaring, 5 are a HOLD (83.33%), 1 are a BUY (16.67%).
Analyst James Mainwaring works at ATLANTIC EQUITIES with a stock forecast success ratio of 44.44% fulfilled within 88.33 days on average.
James Mainwaring’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 01-Jun-2022.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $10.44 (8.38%) receiving and performance score of 0.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
163
$18.54 (12.83%)
135
17 days ago
7/9 (77.78%)
$21.66 (15.32%)
81
Hold
132
$-12.46 (-8.63%)
120
1 months 25 days ago
7/8 (87.5%)
$-5.01 (-3.66%)
151
Sell
125
$-19.46 (-13.47%)
120
1 months 25 days ago
10/12 (83.33%)
$-12.01 (-8.77%)
137
Sell
120
$-24.46 (-16.93%)
100
2 months 28 days ago
4/6 (66.67%)
$-9.88 (-7.61%)
109
Buy
165
$20.54 (14.22%)
150
4 months 2 days ago
6/9 (66.67%)
$27.05 (19.61%)
268
What Year was the first public recommendation made by James Mainwaring?